0001549595-14-000001.txt : 20140102 0001549595-14-000001.hdr.sgml : 20140101 20140102162616 ACCESSION NUMBER: 0001549595-14-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20140102 DATE AS OF CHANGE: 20140102 EFFECTIVENESS DATE: 20140102 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Nurix, Inc. CENTRAL INDEX KEY: 0001549595 IRS NUMBER: 270838048 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-209160 FILM NUMBER: 14502130 BUSINESS ADDRESS: STREET 1: 1700 OWENS STREET, SUITE 500 CITY: SAN FRANCISCO STATE: CA ZIP: 94158 BUSINESS PHONE: (415) 865-2057 MAIL ADDRESS: STREET 1: 1700 OWENS STREET, SUITE 500 CITY: SAN FRANCISCO STATE: CA ZIP: 94158 D 1 primary_doc.xml X0707 D LIVE 0001549595 Nurix, Inc. 1700 OWENS STREET, SUITE 500 SAN FRANCISCO CA CALIFORNIA 94158 (415) 865-2057 DELAWARE Kura Therapeutics, Inc. None Corporation true 2009 Timothy Kutzkey 1700 Owens St., Suite 500 San Francisco CA CALIFORNIA 94158 Executive Officer Director David Goeddel 1700 Owens St., Suite 500 San Francisco CA CALIFORNIA 94158 Director Mark Goldsmith 1700 Owens St., Suite 500 San Francisco CA CALIFORNIA 94158 Executive Officer Director Other Decline to Disclose 06b false 2013-12-18 true true false 0 25150000 2075000 23075000 Proceeds are to be used for working capital. false 2 0 0 0 false Nurix, Inc. /s/ Michael E. Tenta Michael E. Tenta Secretary 2013-12-31